dermatopathologists classify challenging and ambiguous melanoma biopsies that traditional histopathology cannot reliably resolve. By capturing tumor and stroma dynamics at a molecular level, the assay supports more individualized oncology insights and aims to reduce diagnostic uncertainty. Frontier Diagnostics also works with external bioinformatics partners to build machine learning frameworks, data analytics pipelines, and software protocols that support its assays. These tools enable analysis and interpretation of complex proteomic imaging data for clinical and research use in oncology diagnostics.